Denali Therapeutics' Avlayah is the first drug for neurological complications associated with the rare lysosomal storage disorder Hunter syndrome to be approved in the US. Enzyme replacement therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results